Contents

Disclaimer

Oxford University Press makes no representation, express or implied, that the drug dosages in this book are correct. Readers must therefore always check the product information and clinical procedures with the most up to date published product information and data sheets provided by the manufacturers and the most recent codes of conduct and safety regulations. The authors and the publishers do not accept responsibility or legal liability for any errors in the text or for the misuse or misapplication of material in this work. Except where otherwise stated, drug dosages and recommendations are for the non-pregnant adult who is not breastfeeding.

Show Summary Details
Page of

Neuropathological Markers in Late-Life Depression 

Neuropathological Markers in Late-Life Depression
Chapter:
Neuropathological Markers in Late-Life Depression
Author(s):

José Javier Miguel-Hidalgo

and Grazyna Rajkowska

DOI:
10.1093/med/9780199796816.003.0036
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 17 February 2020

Neuroimaging and clinical studies of late-life depression point to neuropathological changes in the prefrontal cortex of subjects with late-life mood disorders. Research on the cellular basis of that neuropathology reveals an age-related increase in neuronal vulnerability in the orbitofrontal and dorsolateral prefrontal cortices, but less so in subcortical regions. Unlike depression earlier in life, late-life depression likely involves activation in the expression of glial markers and possibly enhancement of glial proliferation. The relationship of glial and neuronal changes to neuroimmune disturbances that occur both in depression and during normal aging remains to be fully characterized, although it may be related to inflammatory disruption in the deep white matter of the prefrontal cortex.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.